Recently, life science companies have faced serious challenges raising financing. While overall venture capital financing in Canada is on the rise compared to past years (though still nowhere near the amounts seen in the early 2000s), life science start-ups are not experiencing the same increase. According to the Industry Canada "Venture Capital Monitor", investment in life sciences companies totalled $40 million during the third quarter of 2013, a decrease of about 56% compared to the same period in 2012.
To read the original article: The New Direction Of Venture Capital Financing - Food, Drugs, Healthcare, Life Sciences - Canada
